April 24, 2024

Virology Market Size To Increase USD 4.26 Billion By 2032

The global virology market size was estimated to be around US$ 2.6 billion in 2022. It is projected to reach US$ 4.26  billion by 2032, indicating a CAGR of 5.10% from 2023 to 2032.

Virology Market Size 2023 To 2032

Key Takeaways

  • North America led the market with the biggest market share of 38% in 2022.
  • Asia-Pacific is projected to expand at the fastest CAGR during the forecast period.
  • By Product Type, the antiviral therapeutics segment has held the largest revenue share of 45% in 2022.
  • By Product Type, the interferons segment is anticipated to grow at a notable CAGR of 6.7% during the projected period.
  • By Application, the respiratory tract infections segment contributed more than 36% of revenue share in 2022.
  • By Application, the eye infections segment is estimated to expand at the fastest CAGR over the projected period.
  • By End User, the hospitals segment has held the largest revenue share 30% in 2022.
  • By End User, the diagnostic centers segment is expected to grow at a CAGR of 7.9% over the predicted period.

Virology Market Overview

The Virology Market is a dynamic sector within the broader field of medical science dedicated to the study of viruses and viral diseases. With a relentless pursuit of understanding, diagnosing, and treating viral infections, the Virology Market plays a pivotal role in global healthcare.

Get a Sample: https://www.precedenceresearch.com/sample/3428

Virology Market Scope

Report Coverage Details
Growth Rate from 2023 to 2032 CAGR of 5.10%
Market Size in 2023 USD 2.72 Billion
Market Size by 2032 USD 4.26 Billion
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Product Type, By Application, and By End User
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read More: Pipettes Market Size to Garner USD 2.04 Billion by 2032

Growth Factors

Several key factors contribute to the continuous growth of the Virology Market. Technological advancements, particularly in molecular diagnostics and genomics, have revolutionized virus detection and research methodologies. The increasing prevalence of viral infections, coupled with a growing global population and international travel, drives the demand for effective virological diagnostics and therapeutics. Additionally, the ongoing efforts in vaccine development and the heightened awareness of emerging infectious diseases further stimulate the market’s expansion.

Focusing on the global Virology market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the Virology market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.

Region Snapshot

The Virology Market exhibits variations and opportunities across different regions. North America stands at the forefront, driven by substantial investments in research and development, a robust healthcare infrastructure, and a proactive approach to viral outbreaks. Europe follows closely, with a focus on collaborative efforts in virological research and a high level of healthcare accessibility.

Virology Market Share, By Region, 2022 (%)
The Asia-Pacific region is experiencing significant growth, propelled by the rising incidence of viral diseases and increasing healthcare expenditure. These regional dynamics collectively contribute to the global landscape of the Virology Market, shaping its trajectory in the coming years.

Recent Developments

  • In May 2022, QuantuMDx Group Limited introduced its latest respiratory panel test, the Q-POC SARS-CoV-2, Flu A/B & RSV Assay. This innovative assay is designed to operate on the Q-POC platform, which boasts multiplex capabilities. This advancement enables users to conduct swift point-of-care testing in various settings, whether clinical or non-clinical.
  • In January 2022, InTec made headlines with the unveiling of its novel and highly sensitive SARS-CoV-2 Rapid Antigen Test, known as the AQ+ Covid-19 Ag Rapid Test. Specifically developed for professional use, this test empowers healthcare professionals and even laypersons to swiftly and conveniently identify COVID-19 cases.

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Virology Market Players

  • GlaxoSmithKline plc
  • Abbott Laboratories
  • Boehringer Ingelheim Corporation
  • Merck and Co. Inc.
  • Novartis International AG
  • Siemens
  • Johnson & Johnson
  • AstraZeneca AB
  • Roche
  • Trinity Biotech

Virology Market Segmentations

By Product Type

  • Diagnosing Test
  • Viral Infection Controlling Methods
  • Antiviral Chemotherapy
  • Interferons

By Application

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Urinary Tract Infections
  • Eye Infections
  • CNS Infections
  • Sexually Transmitted Diseases
  • Perinatal Infections

By End User

  • Hospitals
  • Clinics
  • Laboratories
  • Diagnostic Centers
  • Blood Banks
  • Pharmacies

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Virology Market 

5.1. COVID-19 Landscape: Virology Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Virology Market, By Product Type

8.1. Virology Market, by Product Type, 2023-2032

8.1.1 Diagnosing Test

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Viral Infection Controlling Methods

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Antiviral Chemotherapy

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Interferons

8.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Virology Market, By Application

9.1. Virology Market, by Application, 2023-2032

9.1.1. Skin and Soft Tissue Infections

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Respiratory Tract Infections

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. GI Tract Infections

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Urinary Tract Infections

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Eye Infections

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Sexually Transmitted Diseases

9.1.6.1. Market Revenue and Forecast (2020-2032)

9.1.7. Perinatal Infections

9.1.7.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Virology Market, By End User 

10.1. Virology Market, by End User, 2023-2032

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Clinics

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Laboratories

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Diagnostic Centers

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Blood Banks

10.1.5.1. Market Revenue and Forecast (2020-2032)

10.1.6. Pharmacies

10.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Virology Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.1.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.3. Market Revenue and Forecast, by End User (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.2.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.6.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.7.3. Market Revenue and Forecast, by End User (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.3.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.6.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.7.3. Market Revenue and Forecast, by End User (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.6.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.7.3. Market Revenue and Forecast, by End User (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.5.3. Market Revenue and Forecast, by End User (2020-2032)

Chapter 12. Company Profiles

12.1. GlaxoSmithKline plc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Abbott Laboratories

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Boehringer Ingelheim Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Merck and Co. Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Novartis International AG

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Siemens

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Johnson & Johnson

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. AstraZeneca AB

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Roche

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Trinity Biotech

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *